President Donald Trump's pick for health secretary, Robert F. Kennedy Jr., said Thursday he believes anti-obesity drugs "have ...

Amy Burroughs, Terns Pharma CEO, joins 'Closing Bell Overtime' to talk progress in its GLP-1 drug development.

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

Musk's plan to cut $2 trillion in federal spending could clash with his proposal to subsidize a drug costing up to $1,000 a ...

That, according to the firm, make them particularly suitable for users of GLP-1 medications. GLP-1 drugs such as Ozempic and ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

Barriers to accessing GLP-1 medications are beginning to break down as drug manufacturers, insurers, and lawmakers look to expand availability, lower costs, and address continued high demand.

American doctors tracking women being treated for an aggressive form of breast cancer have discovered the drug 'detrimentally affects' how the body responds to cancer treatments.

Robert F. Kennedy Jr., a prominent critic of the pharmaceutical industry, discussed his views regarding GLP-1 weight loss drugs in a televised broadcast.

In the age of weight-loss drugs like Ozempic and Wegovy, major food companies are adding new products to their lineups, The ...

The View” co-host Whoopi Goldberg accused Health and Human Services (HHS) nominee Robert F. Kennedy Jr. of fat shaming ...